Cholic acid
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- Changes in Glutathione Content in Liver Diseases: an Update
- Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
- Obeticholic Acid: First Global Approval
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Suppl Table 2.Xlsx
- Glycyrrhizin Alleviates Non-Alcoholic Steatohepatitis Via Modulating Bile Acids and Meta
- Gastrointestinal Drug Advisory Committee (GIDAC) Meeting
- Treatment with Milk Thistle Extract (Silybum Marianum
- Download Product Insert (PDF)
- TGR5 As New Target in Diabetes Care
- Efficacy of Hepatoprotective Agents with Or Without Antiviral Drugs on Liver Function and Fibrosis in Patients with Hepatitis B: a Meta-Analysis
- Functional Disorders in the Sphincter of Oddi and Possibly Reflux-Associated Diseases in the Hepato-Biliary-Cholecysto-Pancreat
- The Role of Ursodeoxycholic Acid on Cholestatic Hepatic Fibrosis in Infant Rats
- Downloaded from the Protein Data Bank (PDB ID: 6VSB)
- Cholic Acid) Capsules, for Oral Use Drink/Food (2.3) Initial U.S
- Characterization of Novel Fluorescent Bile Salt Derivatives for Studying Human Bile Salt and Organic Anion Transporters S
- (12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
- Drug-Induced Liver Lesions: Modern Approaches to Treatment N. B. Gubergrits1, N